Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004952405 | SCV005548713 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-07-31 | criteria provided, single submitter | clinical testing | The p.E2475A variant (also known as c.7424A>C), located in coding exon 13 of the BRCA2 gene, results from an A to C substitution at nucleotide position 7424. The glutamic acid at codon 2475 is replaced by alanine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |